build a website




la bibliografia

scopri le fonti di tutto ciò che ti diciamo



bibliografia sangue e tessuto cordonale

1) Cells. 1996 Jul;14(4):430-8.Functional and morphological characterization of immunomagnetically selected CD34+ hematopoieticprogenitor cells.Servida F, Soligo D, Caneva L, Bertolini F, de Harven E, Campiglio S, Corsini C, Deliliers GL.Fondazione Matarelli, Ospedale Maggiore, IRCCS, Milan, Italy

2) Curr Immunol Rev. 2010 Aug 1;6(3):167-173.Immune system modulates the function of adult neural stem cells.Gonzalez-Perez O, Jauregui-Huerta F, Galvez-Contreras AY. Neuroscience Laboratory, Psychology School, University of Colima, Colima, Mexico 28040

3) Haematologica. 2010 Jul;95(7):1061-7. Epub 2010 Jan 15.Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligandadministration.de Kruijf EJ, Hagoort H, Velders GA, Fibbe WE, van Pel M

4) Folia Histochem Cytobiol. 2006;44(1):53-60.Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis productand bone marrow for clinical transplantation: a comparison of three methods.Gajkowska A, Oldak T, Jastrzewska M, Machaj EK, Walewski J, Kraszewska E, Pojda Z

5) Clin Immunol. 2008 Jun;127(3):286-97. Epub 2008 Apr 18.Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Brown JA, Boussiotis VA

6) Proc Natl Acad Sci U S A. 1989 May;86(10):3828-32.Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D, Arny M, Thomas L, Boyse EA

7) Rev Lat Am Enfermagem. 2010 Jul-Aug;18(4):716-24.Infusion of hematopoietic stem cells: types, characteristics, adverse and transfusion reactions and theimplications for nursing.Curcioli AC, de Carvalho EC

8) Nat Rev Cancer. 2003 Jul;3(7):526-32. Umbilical-cord blood transplantation for the treatment of cancer.Barker JN, Wagner JE

9) Bone Marrow Transplant. 2010 Feb;45(2):219-34. Epub 2009 Jul 6.Allogeneic and autologous transplantation for haematological diseases, solid tumours and immunedisorders: current practice in Europe 2009.Ljungman P, Bregni M, Brune M, Cornelissen J, de Witte T, Dini G, Einsele H, Gaspar HB, Gratwohl A,Passweg J, Peters C, Rocha V, Saccardi R, Schouten H, Sureda A, Tichelli A, Velardi A, Niederwieser D;European Group for Blood and Marrow Transplantation

10) Bone Marrow Transplantation (2009) 43, 275–291The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapiesA Gratwohl1, H Baldomero1, A Schwendener2, V Rocha3, J Apperley4, K Frauendorfer2 and DNiederwieser 5, for the Joint Accreditation Committee of the International Society for CellularTherapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE)

11) Stem Cells. 2007 Apr;25(4):818-27.Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-basedtherapies.Schäffler A, Büchler C

12) Stem Cells. 2007 Jan;25(1):69-77. Epub 2006 Sep 14.Concise review: multipotent mesenchymal stromal cells in blood.He Q, Wan C, Li G

13) Trends Immunol. 2007 May;28(5):219-26. Epub 2007 Apr 2. Mesenchymal stem cells: a new strategy for immunosuppression? Uccelli A, Pistoia V, Moretta L

14) Blood. 2007 Feb 15;109(4):1743-51. Epub 2006 Oct 24.SSEA-4 identifies mesenchymal stem cells from bone marrow. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC

15) Int J Clin Exp Med. 2010 Sep 7;3(4):248-69.Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Malgieri A, Kantzari E, Patrizi MP, Gambardella S

16) Biol Blood Marrow Transplant. 2007 Dec;13(12):1477-86. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H

17) Stem Cells. 2008 Feb;26(2):300-11. Epub 2007 Nov 1.Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M,Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G,Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC

18) Cord blood hematopoietic stem cell transplantationHal E Broxmeyer § Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202,USAPublished May 26, 2010

19) Barker JN, Wagner JE.Umbilical-cord blood transplantation for the treatment of cancerNat Rev Cancer 2003;3:526–532. [PubMed: 12835672]

20) Clin Immunol. 2008 June ; 127(3): 286–297. doi:10.1016/j.clim.2008.02.008 Umbilical Cord Blood Transplantation: Basic Biology and Clinical Challenges to Immune ReconstitutionJulia Brown1 and Vassiliki A. Boussiotis

21) Morrison SJ, Wandycz AM, Akashi K, Globerson A, Weissman IL.The aging of hematopoietic stem cells.Nat Med 1996;2:1011-6

22) Mayani H, Lansdorp PM.Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood.Blood 1994;83:2410-7

23) Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994;91:9857-60

24) N Engl J Med. 1997 Aug 7;337(6):373-81. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group andthe European Blood and Marrow Transplantation Group.Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, FerreiraE, Laporte JP, Fernandez M, Chastang C

25) Bone Marrow Transplantation (2009) 43, 275–291. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. A Gratwohl1, H Baldomero1, A Schwendener2, V Rocha3, J Apperley4, K Frauendorfer2 and

26) DNiederwieser 5, for the Joint Accreditation Committee of the International Society for CellularTherapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE)

27) Falcon, Krauss, Gunter 2006 Abstract #45 ISCT

28) Ferreira et al. 1999 Bone Marrow Transplantation 24:1041

29) Fruchtman et al. 2001 Poster #2872 ASH#43

30) Fruchtman et al. 2004 Biol. Blood Marrow Transplantation 10(11):741-2

31) Harris, Mapother, Brown 2003 Poster #6 ISCT

32) Hayani et al. 2007 Pediatrics 119:296-300

33) Hough et al. 2003 Poster #5306 ASH #45 in Blood 102(11)

34) Thornley et al. 2004 Blood 104(11)

35) Husakova & Sejnova 2008 SIOP abstract

36) Papadopoulos et al. 2008 23rd Royal Thai COG Abstract

37) Papadopoulos, Low & Aw 2009 2nd international congress on Responsible Stem Cell Research (RSCR,Nov. 26-28, Monaco) Abstract #24

38) www.parentsguidecordblood.org

39) www.clinicaltrial.gov

40) Decreto 18 Novembre 2009 emanato dal Ministero del Lavoro, della Salute e delle PoliticheSociali

41) Atti del Congresso Nazionale ADISCO, Maggio 2011, Roma

42) Decreto Ministeriale 22 Aprile 2014

43) Report 2014 Centro Nazionale Sangue

bibliografia e referenze altri servizi

International Society for Neonatal Screening

SISMME-SISN Linee Guida per Screening Esteso e Conferma –Versione Definitiva - Maggio 2008

Le nuove frontiere dello screening neonatale L’era della “tandem mass”, Carlo Corbetta, AISMME News, Numero 6 Gennaio Giugno 2010

MedlinePlus: newborn screening

http://www.newbornscreening.info/

Si sono espressi a favore dello screening neonatale allargato, tra gli altri:

AISMME Associazione Italiana Sostegno Malattie metaboliche ereditarie

AMMeC Associazione Malattie Metaboliche Congenite

Cometa A.S.M.M.E. Associazione Studio Malattie Metaboliche Ereditarie

SISMME Società Italiana per lo studio delle Malattie Metaboliche Ereditarie e lo Screening Neonatale

Nila Medica S.r.l.
Sede legale: Via Corfù 54, 25124 Brescia
P.IVA e C.F.: 03738320989
REA: BS 558966
Capitale: Euro 10.000,00 i.v.
PEC: nilamedica@pec.it
Tel. 030 2423952
e -mail info@nilamedica.com 
© copyright 2015 - 2019 tutti i diritti sono riservati
data ultima modifica: 07/06/2019 
Privacy Policy
Le informazioni contenute nel presente sito e nei siti correlati sono volte a migliorare, e non a sostituire, il rapporto medico paziente.
Nessuna delle informazioni riportate ha lo scopo di aiutare nella diagnosi di patologie e/o di indicare possibili terapie.

Se pensate di essere malati, consultate un medico.